ロード中...
Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production
Obesity is growing rapidly worldwide due to consumption of westernized diet and lack of exercise. Obesity is one of the major risk factors of hypertension. The novel histone deacetylase (HDAC) inhibitor CG200745 was originally developed to treat various cancers. Previous studies showed that CG200745...
保存先:
| 出版年: | Naunyn Schmiedebergs Arch Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280340/ https://ncbi.nlm.nih.gov/pubmed/31655853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-019-01749-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|